HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Root, C. Articles by Lewis, M. C. Search for Related Content PubMed PubMed Citation Articles by Root, C. Articles by Lewis, M. C. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 36, 1106-1115, Copyright © 1995 by Lipid Research, Inc.

ARTICLES

Inhibition of ileal sodium-dependent bile acid transport by 2164U90

C Root, CD Smith, DA Winegar, LE Brieaddy and MC Lewis
Division of Pharmacology, Burroughs Wellcome Co., Research Triangle Park, NC 27709, USA.

Inhibition of the ileal bile acid active transport system, previously shown to be mechanism underlying the hypocholesterolemic activity of 2164U90 in rodents, was further characterized in isolated intestinal preparations from three species. 2164U90 inhibited sodium-dependent transport of taurocholic acid by Caco-2 cells and by monkey and human ileal brush border membrane vesicles in a concentration-dependent manner with IC50s of 7 microM, 5 microM, and 2 microM, respectively. In rat ileal brush border membrane vesicles, 2164U90 was a competitive inhibitor of sodium-dependent taurocholic acid uptake with an estimated Ki of 1.8 +/- 0.2 microM. In anesthetized rats, 5 microM 2164U90 placed in the isolated distal ileum with 3 mM [3H]taurocholic acid decreased ileal uptake, transport into the bile, and transport rate of taurocholic acid by 31-35%. Stereospecificity of inhibition by 2164U90 was demonstrated by the relative inactivity of three other possible stereoisomers in rat ileal sacs and brush border membrane vesicles. 2164U90 did not inhibit sodium-dependent glucose transport by monkey jejunal brush border membrane vesicles, indicating that 2164U90 may be specific for the bile acid transporter. These results suggest that 2164U90 is a potent, selective, stereospecific, competitive inhibitor of the sodium-dependent bile acid transporter in the ileal mucosal cell brush border membrane.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Sakamoto, H. Kusuhara, K. Miyata, H. Shimaoka, T. Kanazu, Y. Matsuo, K. Nomura, N. Okamura, S. Hara, K. Horie, et al. Glucuronidation Converting Methyl 1-(3,4-Dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) to a Potent Apical Sodium-Dependent Bile Acid Transporter Inhibitor, Resulting in a Hypocholesterolemic Action J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 610 - 618. [Abstract] [Full Text] [PDF]

				N. Hussainzada, A. Banerjee, and P. W. Swaan Transmembrane Domain VII of the Human Apical Sodium-Dependent Bile Acid Transporter ASBT (SLC10A2) Lines the Substrate Translocation Pathway Mol. Pharmacol., November 1, 2006; 70(5): 1565 - 1574. [Abstract] [Full Text] [PDF]

				C Thomas, J-F Landrier, D Gaillard, J Grober, M-C Monnot, A Athias, and P Besnard Cholesterol dependent downregulation of mouse and human apical sodium dependent bile acid transporter (ASBT) gene expression: molecular mechanism and physiological consequences Gut, September 1, 2006; 55(9): 1321 - 1331. [Abstract] [Full Text] [PDF]

				W. A. Alrefai, Z. Sarwar, S. Tyagi, S. Saksena, P. K. Dudeja, and R. K. Gill Cholesterol modulates human intestinal sodium-dependent bile acid transporter Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G978 - G985. [Abstract] [Full Text] [PDF]

				B. G. Bhat, S. R. Rapp, J. A. Beaudry, N. Napawan, D. N. Butteiger, K. A. Hall, C. L. Null, Y. Luo, and B. T. Keller Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435 J. Lipid Res., September 1, 2003; 44(9): 1614 - 1621. [Abstract] [Full Text] [PDF]

				D. E. Telford, J. Y. Edwards, S. M. Lipson, B. Sutherland, P. H. R. Barrett, J. R. Burnett, E. S. Krul, B. T. Keller, and M. W. Huff Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB J. Lipid Res., May 1, 2003; 44(5): 943 - 952. [Abstract] [Full Text] [PDF]

				M. W. Huff, D. E. Telford, J. Y. Edwards, J. R. Burnett, P. H. R. Barrett, S. R. Rapp, N. Napawan, and B. T. Keller Inhibition of the Apical Sodium-Dependent Bile Acid Transporter Reduces LDL Cholesterol and ApoB by Enhanced Plasma Clearance of LDL ApoB Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1884 - 1891. [Abstract] [Full Text] [PDF]

				C. Root, C. D. Smith, S. S. Sundseth, H. M. Pink, J. G. Wilson, and M. C. Lewis Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94 J. Lipid Res., August 1, 2002; 43(8): 1320 - 1330. [Abstract] [Full Text] [PDF]

				N. N. Izzat, M. E. Deshazer, and D. S. Loose-Mitchell New Molecular Targets for Cholesterol-Lowering Therapy J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 315 - 320. [Abstract] [Full Text]

				K.-H. Baringhaus, H. Matter, S. Stengelin, and W. Kramer Substrate specificity of the ileal and the hepatic Na+/bile acid cotransporters of the rabbit. II. A reliable 3D QSAR pharmacophore model for the ileal Na+/bile acid cotransporter J. Lipid Res., December 1, 1999; 40(12): 2158 - 2168. [Abstract] [Full Text] [PDF]

				W. Kramer, S. Stengelin, K.-H. Baringhaus, A. Enhsen, H. Heuer, W. Becker, D. Corsiero, F. Girbig, R. Noll, and C. Weyland Substrate specificity of the ileal and the hepatic Na+/bile acid cotransporters of the rabbit. I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters J. Lipid Res., September 1, 1999; 40(9): 1604 - 1617. [Abstract] [Full Text]